Why an Israeli company is developing an oral Covid-19 vaccine | Malay Mail

  • 📰 malaymail
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 86%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

JERUSALEM, Aug 2 — Imagine a Covid-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes.  Israeli pharmaceutical Oramed is attempting to accomplish just that, and is poised to start its first...

JERUSALEM, Aug 2 — Imagine a Covid-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes.

Oral vaccines are particularly attractive for the developing world, because they reduce the logistical burden of immunisation campaigns, said Kidron. “In order for the vaccine to really work well, we need as many people to take it as possible,” said Kidron.Challenges for oral delivery Oramed, which was founded in 2006, believes it has overcome the technical hurdles by designing a capsule that survives the highly acidic environment of the gut.

It also releases molecules called protease inhibitors that stop enzymes in the small intestine from breaking down the insulin, and an absorption enhancer to help the insulin cross into the bloodstream. These mimic three key structures of the pathogen: the spike protein, the envelope protein and the membrane protein.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 1. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها